16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy.

      Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
      Adult, Antiretroviral Therapy, Highly Active, adverse effects, CD4 Lymphocyte Count, DNA, Viral, blood, Female, HIV Infections, complications, HIV-1, immunology, physiology, Herpesvirus 8, Human, genetics, Humans, Immune System Diseases, etiology, Inflammation, Male, Paclitaxel, therapeutic use, Sarcoma, Kaposi, virology, Syndrome, Viral Load

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Rapidly progressive Kaposi sarcoma (KS) lesions with lymphadenopathy and tissue swelling occurred in a patient during antiretroviral treatment, despite an increased CD4(+) lymphocyte count and decreased HIV-1 level and KS-associated herpesvirus replication, suggesting immune reconstitution inflammatory syndrome. Inflammation resolved coincident with decreases in the CD4(+) lymphocyte count during paclitaxel treatment, whereas KS cleared only after prolonged antiretroviral therapy and chemotherapy.

          Related collections

          Author and article information

          Comments

          Comment on this article